FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

28400711000001102: Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89302201000001114 Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
89302301000001117 Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Is a Quetiapine 300mg modified-release tablets 60 tablet true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has AMP Biquelle XL 300mg tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient Quetiapine fumarate true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd) 60 tablet 6 x 10 tablets Has basis of strength substance Quetiapine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start